Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus

The Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated in 2012, and circulated worldwide with high mortality. The continual outbreaks of MERS-CoV highlight the importance of developing antiviral therapeutics. Here, we rationally designed a novel fusion inhibitor named MERS-fi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yaping Sun, Huaidong Zhang, Jian Shi, Zhe Zhang, Rui Gong
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2017-09-01
Col·lecció:	Viruses
Matèries:	MERS-CoV fusion inhibitor six-helix bundle heptad repeat five-helix bundle
Accés en línia:	https://www.mdpi.com/1999-4915/9/9/255
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!